0001567619-23-000800.txt : 20230111 0001567619-23-000800.hdr.sgml : 20230111 20230111135147 ACCESSION NUMBER: 0001567619-23-000800 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230111 DATE AS OF CHANGE: 20230111 EFFECTIVENESS DATE: 20230111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALZHEON, INC. CENTRAL INDEX KEY: 0001582636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463074149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-470344 FILM NUMBER: 23523257 BUSINESS ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 857-214-7242 MAIL ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 D 1 primary_doc.xml X0708 D LIVE 0001582636 ALZHEON, INC. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 508-861-7709 DELAWARE None None Corporation true Martin Tolar, M.D., Ph.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Executive Officer President and Chief Executive Officer Kenneth A. Mace 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Treasurer and Chief Financial Officer Neil W. Flanzraich 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Jordan Heller 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Christopher Noel Dunn 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Diane K. Jorkasky, M.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Susan Abushakra, M.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Medical Officer John Hey, Ph.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Scientific Officer Aidan Power, MRCPsych 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Development Officer Biotechnology Decline to Disclose 06b false 2022-12-27 true true false 0 50004201 1703768 48300433 false 6 0 0 0 false ALZHEON, INC. /s/ Martin Tolar, M.D., Ph.D. Martin Tolar, M.D., Ph.D. President and Chief Executive Officer 2023-01-11